The demand for dermatological drugs in Bangladesh has been steadily increasing in recent years.
Customer preferences: Bangladesh has a large population, and a significant portion of it suffers from various skin conditions. As a result, there is a growing demand for dermatological drugs in the country. Consumers in Bangladesh prefer affordable and easily accessible drugs that can treat their skin problems effectively. They also tend to prefer products that are made from natural ingredients.
Trends in the market: The dermatological drugs market in Bangladesh has been growing due to several factors. One major trend is the increasing prevalence of skin diseases in the country. Skin conditions such as acne, psoriasis, and eczema are becoming more common in Bangladesh, leading to a higher demand for dermatological drugs. Another trend is the growing popularity of herbal and natural products, which are seen as safe and effective alternatives to traditional pharmaceuticals.
Local special circumstances: Bangladesh is a developing country with a large population, and its healthcare system is still evolving. Many people in the country do not have access to quality healthcare, which has led to a rise in self-medication. As a result, there is a large market for over-the-counter dermatological drugs in Bangladesh. Additionally, the country has a large number of small pharmacies and drugstores, which make it easy for consumers to purchase dermatological drugs.
Underlying macroeconomic factors: The economy of Bangladesh has been growing steadily in recent years, which has led to an increase in disposable income for many consumers. This has allowed more people to afford dermatological drugs and other healthcare products. Additionally, the government of Bangladesh has been investing in healthcare infrastructure and services, which has helped to improve access to healthcare for many people in the country. These factors are expected to continue driving growth in the dermatological drugs market in Bangladesh.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
